F.A.Q.
St. Jude Medical is renowned for its pioneering contributions to the field of medical technology, particularly in cardiovascular and neuromodulation care. The company is known for developing innovative devices such as pacemakers, defibrillators, and neurostimulation devices.
St. Jude Medical has been a trailblazer in the development of technologies like implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. These advancements have revolutionized the treatment of heart rhythm disorders and significantly improved patient outcomes.
St. Jude Medical places a strong emphasis on understanding and meeting the individual needs of patients. The company designs its products with a focus on enhancing patient well-being and ensuring they receive the best possible care and outcomes.
Neuromodulation involves using targeted electrical stimulation to modulate nervous system activity. St. Jude Medical is a leader in this field, providing neurostimulation devices that offer relief to patients with chronic pain, movement disorders, and other neurological conditions.
In 2017, St. Jude Medical became a part of Abbott Laboratories, a global healthcare company. This acquisition has strengthened the company’s ability to deliver comprehensive healthcare solutions by combining Abbott’s expertise in diagnostics, medical devices, nutrition, and pharmaceuticals with St. Jude Medical’s cutting-edge technologies.